Cargando…

Commonality Between Diabetes and Alzheimer’s Disease and A New Strategy for the Therapy

Detalles Bibliográficos
Autor principal:	Lin, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160008/ https://www.ncbi.nlm.nih.gov/pubmed/21876656

Ejemplares similares

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
por: Michailidis, Michalis, et al.
Publicado: (2022)

Commonalities between Copper Neurotoxicity and Alzheimer’s Disease
por: Patel, Roshni, et al.
Publicado: (2021)

New strategies for Alzheimer disease and cognitive impairment
por: Maiese, Kenneth, et al.
Publicado: (2009)

Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
por: Ahn, Kee-Chan, et al.
Publicado: (2019)

New treatment strategies for Alzheimer's disease: is there a hope?
por: Aprahamian, Ivan, et al.
Publicado: (2013)

Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
por: Potenza, Maria Assunta, et al.
Publicado: (2021)

Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

Prevention strategies for Alzheimer’s disease
por: Gauthier, Serge, et al.
Publicado: (2012)

The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers
por: Kubis-Kubiak, Adriana, et al.
Publicado: (2020)

Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
por: Rana, Pratip, et al.
Publicado: (2019)

The past and present of therapeutic strategy for Alzheimer’s diseases: potential for stem cell therapy
por: Murayama, Masanori A.
Publicado: (2023)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
por: Hamzé, Rim, et al.
Publicado: (2022)

Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
por: Zimbone, Stefania, et al.
Publicado: (2023)

Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies
por: Ashraf, Ghulam Md, et al.
Publicado: (2021)

Neuroinflammation: A Common Pathway in Alzheimer’s Disease and Epilepsy
por: Liew, Yee, et al.
Publicado: (2023)

A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
por: Park, Sun Ah
Publicado: (2011)

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer’s disease: a narrative review
por: Sarahian, Nahid, et al.
Publicado: (2021)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Alzheimer’s Disease: Treatment Strategies and Their Limitations
por: Passeri, Elodie, et al.
Publicado: (2022)

Solving neurodegeneration: common mechanisms and strategies for new treatments
por: Wareham, Lauren K., et al.
Publicado: (2022)

Stem cell therapy for Alzheimer's disease
por: Liu, Xin-Yu, et al.
Publicado: (2020)

Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer’s disease: an updated overview of nonpharmacological therapies
por: Formolo, Douglas A., et al.
Publicado: (2023)

Common Factors of Alzheimer’s Disease and Rheumatoid Arthritis—Pathomechanism and Treatment
por: Trzeciak, Paulina, et al.
Publicado: (2021)

Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
por: Chen, Yuan-Yuan, et al.
Publicado: (2020)

The Development of Pharmacological Therapies for Alzheimer’s Disease
por: Lin, Ping, et al.
Publicado: (2021)

Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation
por: Miklossy, Judith, et al.
Publicado: (2016)

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
por: Huang, Pei, et al.
Publicado: (2023)

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
por: Zagórska, Agnieszka, et al.
Publicado: (2020)

The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
por: Wang, Tao, et al.
Publicado: (2023)

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?
por: Jiao, Fengjuan, et al.
Publicado: (2022)

Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies
por: Shabbir, Umair, et al.
Publicado: (2021)

Immunotherapeutic Strategies for Alzheimer's Disease Treatment
por: Solomon, Beka
Publicado: (2009)

Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
por: Ju, Yaojun, et al.
Publicado: (2021)

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
por: Jia, Lin, et al.
Publicado: (2019)

Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
por: Veselov, Ivan M., et al.
Publicado: (2023)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova, Blanka, et al.
Publicado: (2017)

Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
por: Fu, Wen, et al.
Publicado: (2013)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li, Xiaohua, et al.
Publicado: (2015)

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
por: Lannfelt, Lars, et al.
Publicado: (2014)

Optogenetic neuromodulation with gamma oscillation as a new strategy for Alzheimer disease: a narrative review
por: Ko, Haneol, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ng1aon1bf4hemljqkq0lscbqa